8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Jul 29, 2014)

Filed July 29, 2014For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) filed an 8-K on July 29, 2014, to report its financial results for the second quarter of 2014. The report primarily serves to furnish a press release detailing the company's performance during the period. Investors should refer to the press release, furnished as Exhibit 99.1, for specific financial metrics and operational highlights. This filing indicates that Edwards Lifesciences met its reporting obligations for Q2 2014 by providing its earnings announcement. While the 8-K itself is a brief administrative filing, the attached press release is the crucial document for understanding the company's financial condition and results of operations during the reporting period, including revenue, profitability, and any significant business developments.

Key Highlights

  • 1Edwards Lifesciences filed an 8-K on July 29, 2014, to announce its second-quarter 2014 financial results.
  • 2The core of the filing is a press release (Exhibit 99.1) containing the company's Q2 2014 financial performance data.
  • 3The filing does not contain new operational or strategic information beyond what is detailed in the provided press release.
  • 4The press release is incorporated by reference into the 8-K filing.
  • 5The information furnished under Item 2.02 is not deemed 'filed' for the purposes of the Securities Exchange Act of 1934.
  • 6Scott B. Ullem, Corporate Vice President and Chief Financial Officer, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce and provide investors with Edwards Lifesciences' financial results for the second quarter of 2014, as detailed in an accompanying press release.

The detailed financial results for Q2 2014 are located in the press release furnished as Exhibit 99.1 to this 8-K filing. This press release contains the specific financial figures and operational details for the quarter.

No, this 8-K filing primarily serves to report financial results. Any strategic updates or business developments would be found within the press release (Exhibit 99.1) itself, as the 8-K filing itself is a brief administrative document in this case.

According to the filing, the information furnished under Item 2.02, including the press release, shall not be deemed to be 'filed' for purposes of the Securities Exchange Act of 1934, as amended. This means it's being provided for informational purposes but doesn't carry the same legal implications as a fully 'filed' document.